DEHYDROEPIANDROSTERONE (DHEA) - ANVISA Registration 10300390562

Access comprehensive regulatory information for DEHYDROEPIANDROSTERONE (DHEA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10300390562 and manufactured by DIAGNOSTICS BIOCHEM CANADA INC. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including LDN LABOR DIAGNOSTIKA NORD GMBH & CO., MONOBIND, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.